tru Independence LLC Makes New $36,000 Investment in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

tru Independence LLC bought a new position in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 700 shares of the company’s stock, valued at approximately $36,000.

A number of other large investors have also modified their holdings of SBIO. Keystone Financial Group bought a new position in ALPS Medical Breakthroughs ETF during the fourth quarter worth about $210,000. Koshinski Asset Management Inc. bought a new position in shares of ALPS Medical Breakthroughs ETF in the fourth quarter valued at approximately $237,000. Crescent Capital Consulting LLC bought a new position in shares of ALPS Medical Breakthroughs ETF in the fourth quarter valued at approximately $307,000. Cetera Investment Advisers bought a new position in shares of ALPS Medical Breakthroughs ETF in the fourth quarter valued at approximately $392,000. Finally, Summit Financial Group Inc. boosted its position in shares of ALPS Medical Breakthroughs ETF by 16.6% in the fourth quarter. Summit Financial Group Inc. now owns 10,550 shares of the company’s stock valued at $540,000 after acquiring an additional 1,500 shares during the period.

SBIO stock opened at $48.01 on Thursday. The firm has a 50 day moving average of $53.31 and a 200-day moving average of $50.85. ALPS Medical Breakthroughs ETF has a 12 month low of $32.23 and a 12 month high of $64.04.

Featured Article: Understanding Average Daily Trade Volume

Want to see what other hedge funds are holding SBIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO).

Institutional Ownership by Quarter for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.